tbuckley/cabot-search huggingface dataset:
In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet
Authors: Gaetano Santulli
Journal: Annals of Internal Medicine (2020)

ACP Journal Club21 January 2020In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplateletGaetano Santulli, MDGaetano Santulli, MDAlbert Einstein College of Medicine–Montefiore University Hospital New York, New York, USA, ITME and University of Naples “Federico II” Naples, Italy (G.S.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJ202001210-006 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationYasuda S, Kaikita K, Akao M, et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381:1103-13. https://pubmed.ncbi.nlm.nih.gov/31475793Clinical Impact RatingsInfectious Disease: References1 Agewall S, Camm J. New ESC/EACTS guidelines for the management of atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2017;3:71-2. [PMID: 28025214] Google Scholar2 Nicholls SJ, Nelson AJ. Rivaroxaban with or without aspirin for the secondary prevention of cardiovascular disease: clinical implications of the COMPASS trial. Am J Cardiovasc Drugs. 2019;19:343-8. [PMID: 30680652] Google Scholar3 Lemesle G. Aspirin on top of anticoagulation in patients with concomitant stable coronary artery disease and atrial fibrillation. Circulation. 2019;139:617-9. [PMID: 30586780] Google Scholar4 Santulli G. Stroke prevention: Learning from the master (and COMMANDER). Sci Transl Med. 2018;10. [PMID: 31031885] Google Scholar5 Borzak S. In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone [Comment]. Ann Intern Med. 2017;167:JC52. [PMID: 29159378] Google Scholar Author, Article, and Disclosure InformationAffiliations: Albert Einstein College of Medicine–Montefiore University Hospital New York, New York, USA, ITME and University of Naples “Federico II” Naples, Italy (G.S.)Disclosures: The commentator has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2922.This article was published at Annals.org on 7 January 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byVascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery 21 January 2020Volume 172, Issue 2Page: JC6KeywordsAtrial fibrillationCoronary artery bypass graftingHemorrhageIntent to treat analysisMortalityMyocardial infarctionPercutaneous coronary interventionSafetyStable coronary artery diseaseUnstable angina ePublished: 21 January 2020 Issue Published: 21 January 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Clinicopathological Significance of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) Expression in Gastric Cancer
Authors: T. Isobe, K. Aoyagi, K. Hashimoto, J. Kizaki, M. Miyagi, K. Koufuji, T. Sasatomi, K. Shirouzu
Journal: Annals of Oncology (2012)
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial
Authors: David K Clarke, Rong Xu, Demetrius Matassov, Theresa E Latham, Ayuko Ota-Setlik, Cheryl S Gerardi, Amara Luckay, Susan E Witko, Luz Hermida, Terry Higgins, Marc Tremblay, Susan Sciotto-Brown, Tracy Chen, Michael A Egan, Janice M Rusnak, Lucy A Ward, John H Eldridge
Journal: The Lancet Infectious Diseases (2020)
Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV
Authors: Kevin E. Lindsay, Daryll Vanover, Merrilee Thoresen, Heath King, Peng Xiao, Peres Badial, Mariluz Araínga, Seong Bin Park, Pooja M. Tiwari, Hannah E. Peck, Emmeline L. Blanchard, Jean M. Feugang, Alicia K. Olivier, Chiara Zurla, Francois Villinger, Amelia R. Woolums, Philip J. Santangelo
Journal: Molecular Therapy (2020)

There is a clear need for low-cost, self-applied, long-lasting approaches to prevent human immunodeficiency virus (HIV) infection in both men and women, even with the advent of pre-exposure prophylaxis (PrEP). Broadly neutralizing antibodies represent an option to improve HIV prophylaxis, but intravenous delivery, cold-chain stability requirements, low cervicovaginal concentrations, and cost may preclude their use. Here, we present an approach to express the anti-GP120 broadly neutralizing antibody PGT121 in the primary site of inoculation, the female reproductive tract, using synthetic mRNA. Expression is achieved through aerosol delivery of unformulated mRNA in water. We demonstrated high levels of antibody expression for over 28 days with a single mRNA administration in the reproductive tract of sheep. In rhesus macaques, neutralizing antibody titers in secretions developed within 4 h and simian-HIV (SHIV) infection of ex vivo explants was prevented. Persistence of PGT121 in vaginal secretions and epithelium was achieved through the incorporation of a glycosylphosphatidylinositol (GPI) anchor into the heavy chain of the antibody. Overall, we present a new paradigm to deliver neutralizing antibodies to the female reproductive tract for the prevention of HIV infections.
Amyloidosis and the kidney.
Journal: BMJ (1973)

Amyloidosis results from deposition of fibrillar proteinaceous material in the extracellular space in organs and tissues. Diagnosis is made microscopically on biopsy by visualizing apple-green birefringence in Congo red-stained sections under polarized light. Renal amyloidosis most often leads to glomerular deposits, resulting in proteinuria. If untreated, progressive decline in renal function can culminate in end stage renal disease. The type of protein that forms the fibrils can vary, but the result is disruption of structure and function.
Human Papillomavirus Vaccination for Adults
Authors: Lauren D. Oshman, Andrew M. Davis
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
P-0230 Panitumumab after Progression on Cetuximab in Patients with Kras Wild-Type Metastatic Colorectal Cancer (MCRC): A Single Institution Experience
Authors: Antonella Marino, Chiara Caliolo, Francesco Sponziello, Angelo Nacci, Annamaria Quaranta, Enrica Mazzoni, Pietro Rizzo, Nicola Calvani, Laura Orlando, Paola Schiavone, Palma Fedele, Maria D'Amico, Margherita Cinefra, Saverio Cinieri
Journal: Annals of Oncology (2012)
エルドハイム・チェスター病の多面的臨床所見および症状: 文献と新たな10症例の包括的レビュー
Authors: Cavalli Giulio, Guglielmi Barbara, Berti Alvise, Campochiaro Corrado, Sabbadini Maria Grazia, Dagna Lorenzo
Journal: Annals of the Rheumatic Diseases (2013)
Mechanical Effects on Right Ventricular Function From Left Bundle Branch Block and Cardiac Resynchronization Therapy
Authors: Petter Storsten, John M. Aalen, Espen Boe, Espen W. Remme, Ola Gjesdal, Camilla Kjellstad Larsen, Øyvind Senstad Andersen, Morten Eriksen, Erik Kongsgaard, Jürgen Duchenne, Jens-Uwe Voigt, Otto A. Smiseth, Helge Skulstad
Journal: JACC. Cardiovascular imaging (2020)
Requirement of Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor–Induced Arthritis, but Not Fcγ Receptor–Mediated Platelet Elimination, in Mice
Authors: Kea Martin, Ratiba Touil, Grozdan Cvijetic, Laura Israel, Yeter Kolb, Sophie Sarret, Stéphanie Valeaux, Elena Degl'Innocenti, Thomas Le Meur, Nadja Caesar, Maureen Bardet, Christian Beerli, Hans‐Guenter Zerwes, Jiri Kovarik, Karen Beltz, Achim Schlapbach, Jean Quancard, Catherine H. Régnier, Marc Bigaud, Tobias Junt, Grazyna Wieczorek, Isabelle Isnardi, Amanda Littlewood‐Evans, Frédéric Bornancin, Thomas Calzascia
Journal: Arthritis & Rheumatology (2020)

Fcγ receptors (FcγR) play important roles in both protective and pathogenic immune responses. The assembly of the CBM signalosome encompassing caspase recruitment domain-containing protein 9, B cell CLL/lymphoma 10, and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT-1) is required for optimal FcγR-induced canonical NF-κB activation and proinflammatory cytokine release. This study was undertaken to clarify the relevance of MALT-1 protease activity in FcγR-driven events and evaluate the therapeutic potential of selective MALT-1 protease inhibitors in FcγR-mediated diseases.Using genetic and pharmacologic disruption of MALT-1 scaffolding and enzymatic activity, we assessed the relevance of MALT-1 function in murine and human primary myeloid cells upon stimulation with immune complexes (ICs) and in murine models of autoantibody-driven arthritis and immune thrombocytopenic purpura (ITP).MALT-1 protease function is essential for optimal FcγR-induced production of proinflammatory cytokines by various murine and human myeloid cells stimulated with ICs. In contrast, MALT-1 protease inhibition did not affect the Syk-dependent, FcγR-mediated production of reactive oxygen species or leukotriene B4 . Notably, pharmacologic MALT-1 protease inhibition in vivo reduced joint inflammation in the murine K/BxN serum-induced arthritis model (mean area under the curve for paw swelling of 45.42% versus 100% in control mice; P = 0.0007) but did not affect platelet depletion in a passive model of ITP.Our findings indicate a specific contribution of MALT-1 protease activity to FcγR-mediated events and suggest that MALT-1 protease inhibitors have therapeutic potential in a subset of FcγR-driven inflammatory disorders.
Wide QRS Complex Tachycardia in an Apparently Healthy Man
Authors: Daniel Liauw, Anthony Dang, Laszlo Littmann
Journal: JAMA Internal Medicine (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
Hope Herth Index (HHI): A Validation Study in Italian Patients with Solid and Haematological Malignancies on Active Oncological Therapies
Authors: C.I. Ripamonti, L. Buonaccorso, A. Maruelli, E. Bandieri, S. Boldini, M.A. Pessi, F. Chiesi, G. Miccinesi
Journal: Annals of Oncology (2012)
Hourly Exposure to Ultrafine Particle Metrics and the Onset of Myocardial Infarction in Augsburg, Germany
Authors: Kai Chen, Alexandra Schneider, Josef Cyrys, Kathrin Wolf, Christa Meisinger, Margit Heier, Wolfgang von Scheidt, Bernhard Kuch, Mike Pitz, Annette Peters, Susanne Breitner
Journal: Environmental Health Perspectives (2020)

Background: Epidemiological evidence on the health effects of ultrafine particles (UFP) remains insufficient to infer a causal relationship that is largely due to different size ranges and exposure metrics examined across studies. Moreover, evidence regarding the association between UFP and cardiovascular disease at a sub-daily timescale is lacking. Objective: We investigated the relationship between different particle metrics, including particle number (PNC), length (PLC), and surface area (PSC) concentrations, and myocardial infarction (MI) at an hourly timescale. Methods: We collected hourly air pollution and meteorological data from fixed urban background monitoring sites and hourly nonfatal MI cases from a MI registry in Augsburg, Germany, during 2005–2015. We conducted a time-stratified case-crossover analysis with conditional logistic regression to estimate the association between hourly particle metrics and MI cases, adjusted for air temperature and relative humidity. We also examined the independent effects of a certain particle metric in two-pollutant models by adjusting for copollutants, including particulate matter (PM) with an aerodynamic diameter of ≤10μm or 2.5μm (PM10 and PM2.5, respectively), nitrogen dioxide, ozone, and black carbon. Results: Overall, a total of 5,898 cases of nonfatal MI cases were recorded. Exploratory analyses showed similar associations across particle metrics in the first 6–12 h. For example, interquartile range increases in PNC within the size range of 10–100 nm, PLC, and PSC were associated with an increase of MI 6 h later by 3.27% [95% confidence interval (CI): 0.27, 6.37], 5.71% (95% CI: 1.79, 9.77), and 5.84% (95% CI: 1.04, 10.87), respectively. Positive, albeit imprecise, associations were observed for PNC within the size range of 10–30 nm and 100–500 nm. Effect estimates for PLC and PSC remained similar after adjustment for PM and gaseous pollutants. Conclusions: Transient exposure to particle number, length, and surface area concentrations or other potentially related exposures may trigger the onset of nonfatal myocardial infraction. https://doi.org/10.1289/EHP5478
Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project
Authors: Núria Fabrellas, Marta Carol, Ester Palacio, Marites Aban, Tommaso Lanzillotti, Gea Nicolao, Maria Teresa Chiappa, Vanessa Esnault, Sabine Graf‐Dirmeier, Jeltje Helder, Andrea Gossard, Mireia Lopez, Marta Cervera, Lacey L. Dols
Journal: Hepatology (2020)

Cirrhosis is a complex disease that is associated with disturbances in different organs besides the liver, including kidneys, heart, arterial circulation, lungs, gut, and brain. As a consequence, patients develop a number of complications that result in frequent hospital admissions and high morbidity and mortality. Patients with cirrhosis require constant and rigorous monitoring both in and outside the hospital. In this context, the role of nurses in the care of patients with cirrhosis has not been sufficiently emphasized and there is very limited information about nursing care of patients with cirrhosis compared with other chronic diseases. The current article provides a review of nursing care for the different complications of patients with cirrhosis. Nurses with specific knowledge on liver diseases should be incorporated into multidisciplinary teams managing patients with cirrhosis, both inpatient and outpatient. Conclusion: Nurses play an important role in the management and prevention of complications of the disease and improvement in patients’ quality of life and bridge the gap between clinicians and families, between primary care and hospital care, and provide medical education to patients and caregivers.
Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma
Authors: Kuancan Liu, Fuan Xie, Tingting Zhao, Rui Zhang, Anding Gao, Yunyun Chen, Haiyan Li, Shihui Zhang, Zhangwu Xiao, Jieping Li, Xiaoqian Hong, Lei Shang, Weifeng Huang, Junkai Wang, Wael El-Rifai, Alexander Zaika, Xi Chen, Jianwen Que, Xiaopeng Lan
Journal: Molecular Therapy (2020)

Esophageal squamous cell carcinoma (ESCC) is a predominant cancer type in developing countries such as China, where ESCC accounts for approximately 90% of esophageal malignancies. Lacking effective and targeted therapy contributes to the poor 5-year survival rate. Recent studies showed that about 30% of ESCC cases have high levels of SOX2. Herein, we aim to target this transcription factor with aptamer. We established a peptide aptamer library and then performed an unbiased screening to identify several peptide aptamers including P42 that can bind and inhibit SOX2 downstream target genes. We further found that P42 overexpression or incubation with a synthetic peptide 42 inhibited the proliferation, migration, and invasion of ESCC cells. Moreover, peptide 42 treatment inhibited the growth and metastasis of ESCC xenografts in mouse and zebrafish. Further analysis revealed that P42 overexpression led to alternations in the levels of proteins that are important for the proliferation and migration of ESCC cells. Taken together, our study identified the peptide 42 as a key inhibitor of SOX2 function, reducing the proliferation and migration of ESCC cells in vitro and in vivo, and thereby offering a potential therapy against ESCC. Esophageal squamous cell carcinoma (ESCC) is a predominant cancer type in developing countries such as China, where ESCC accounts for approximately 90% of esophageal malignancies. Lacking effective and targeted therapy contributes to the poor 5-year survival rate. Recent studies showed that about 30% of ESCC cases have high levels of SOX2. Herein, we aim to target this transcription factor with aptamer. We established a peptide aptamer library and then performed an unbiased screening to identify several peptide aptamers including P42 that can bind and inhibit SOX2 downstream target genes. We further found that P42 overexpression or incubation with a synthetic peptide 42 inhibited the proliferation, migration, and invasion of ESCC cells. Moreover, peptide 42 treatment inhibited the growth and metastasis of ESCC xenografts in mouse and zebrafish. Further analysis revealed that P42 overexpression led to alternations in the levels of proteins that are important for the proliferation and migration of ESCC cells. Taken together, our study identified the peptide 42 as a key inhibitor of SOX2 function, reducing the proliferation and migration of ESCC cells in vitro and in vivo, and thereby offering a potential therapy against ESCC.
Health Service Research in Integrative Oncology: Viscum Album Use and Non-Pharmacotherapeutic Interventions in Lung Cancer Patients
Authors: F. Schad, J. Axtner, A. Happe, T. Breitkreuz, J. Gutsch, B. Matthes, C. Grah, G. Spahn, H. Matthes, M. Kroez
Journal: Annals of Oncology (2012)
Different Clinical Outcome of Metastatic Colorectal Cancer (MCRC) Patients Treated with Intensive Triplet Chemotherapy Plus Bevacizumab (FIR-B/FOX) According to Kras Genotype and Disease Extension
Authors: G. Bruera, K. Cannita, D. Di Giacomo, A. Lamy, A. Dal Mas, T. Frebourg, J.C. Sabourin, M. Tosi, C. Ficorella, E. Ricevuto
Journal: Annals of Oncology (2012)
Nuclear Factor-Kappa B as a Molecular Target in Malignant Pleural Mesothelioma
Authors: K.A. Gately, E. Jennions, P. Godwin, M. Barr, S. Heavey, K. Umezawa, J. Edwards, S.G. Gray, K.J. O'Byrne
Journal: Annals of Oncology (2012)
Severe Encasement of Superior Mesenteric Artery or Celiac Artery Relates Pain and Gastrointestinal Symptoms in Patients Receiving Chemotherapy for Advanced Pancreatic Cancer
Authors: S. Mitsunaga, M. Ikeda, I. Ohno, S. Shimizu, H. Takahashi, H. Okuyama, A. Kuwahara, T. Okusaka, H. Ueno, C. Morizane, S. Kondo, A. Ochiai
Journal: Annals of Oncology (2012)
P-0240 Long-Term Bevacizumab Treatment in Patients with Metastatic Colorectal Cancer who are Receiving FOLFOX4 and Folfiri Chemotherapy
Authors: Irina Davidenko, Margarita Kazantseva, Sergey Potemin, Karina Elizbaryan, Elena Mamaeva, Oksana Burdik
Journal: Annals of Oncology (2012)
Conformity to Clinical Practices Guidelines (CPGS) in a Prospective Cohort of Sarcoma Patients Managed for First Diagnosis in the Rhone-Alpes Region
Authors: P. Heudel, C. Cropet, G. De Laroche, P. Cousin, P. Biron, P. Pauwels, F. Farsi, D. Cellier, J. Blay, I.L. Ray-Coquard
Journal: Annals of Oncology (2012)
Utility of Magnetic Resonance Imaging Following Long-Course Pre-Operative Chemo-Radiotherapy for Locally Advanced Rectal Cancer
Authors: D.J. Lucey, A. Murphy, V. Curran, M. McCourt, E. Andrews, M. O'Riordain, D.G. Power, S. O'Reilly, P.J. Kelly
Journal: Annals of Oncology (2012)
Anti-Emetic Therapy for HBV Carrier or Diabetic Breast Cancer: Non-Dexamethasone Containing Combination Treatment of Preventing Emesis of Anthracycline Regimens in Breast Cancer Patients
Authors: Y. Nakayama, Y. Ito, I. Fukata, T. Kobayashi, C. Tsutsumi, S. Takahashi, K. Hatake
Journal: Annals of Oncology (2012)
A Highly Stretchable, Real‐Time Self‐Healable Hydrogel Adhesive Matrix for Tissue Patches and Flexible Electronics
Authors: Jun Luo, Jiaojiao Yang, Xiaoran Zheng, Xiang Ke, Yantao Chen, Hong Tan, Jianshu Li
Journal: Advanced Healthcare Materials (2020)

Abstract The development of biocompatible self‐healable hydrogel adhesives for skin or wet, stretchable surfaces in air or under water is highly desirable for various biomedical applications ranging from skin patches to bioelectronics. However, it has been proven to be very challenging because most existing hydrogel adhesives are cytotoxic, or poorly adhere to dynamic or stretchable surfaces in wet environments. In this study, multifunctional hydrogel adhesives derived from silk fibroin (SF) and tannic acid (TA) are effectively constructed with high extensibility (i.e., up to 32 000%), real‐time self‐healing capability, underwater adhesivity, water‐sealing ability, biocompatibility, and antibiotic properties. According to all‐atom molecular dynamics simulation studies, the properties of the hydrogel adhesives, especially high extensibility, are mainly attributed to the hydrogen bonds between TA and the SF chains in water, and water and TA molecules can result in loose assemblies with fewer β‐sheets, and more random coils in the SF. Conductivity can also be easily introduced to the adhesive matrix and adjusted when the strain of the adhesives occurs. Considering that it has multiple functions and can be efficiently prepared, the proposed hydrogel adhesives have the potential for future medical applications, such as tissue adhesives and integrated bioelectronics.
P-0274 Liver Metastatic Colorectal Cancer (Mcrc) Bevacizumab Treated: CT Evaluation Using Software that Automatically Generates Report According to Recist Criteria
Authors: Flavia Longo, Franco Lafrate, Daniela Adua, Paolo Baldassarri, Gabriella Del Bene, Lucilla De Filippis, Vittoria Lapadula, Viviana Frantellizzi, Paola Gazzaniga, Luigi Frati
Journal: Annals of Oncology (2012)
Phase II Study of Amrubicin (AMR) for Patients with Non-Small Cell Lung Cancer (NSCLC) as Third-Line or Fourth-Line Chemotherapy: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901
Authors: K. Itoh, T. Harada, K. Takamura, E. Kikuchi, S. Ohizumi, S. Sugawara, M. Maemondo, Y. Fujita, I. Kinoshita, A. Inoue, F. Hommura, Y. Katsuura, H. Dosaka-Akita, H. Isobe, M. Nishimura
Journal: Annals of Oncology (2012)